This article provides a pragmatic approach for primary care following NICE’s update to their guidance on identification and management of familial hypercholesterolaemia (CG 71) published in November 2017.
HEART UK - The Cholesterol Charity - has provided editorial support and review of this sponsored FH series.
This article was made possible by an unrestricted educational grant by Sanofi, who had no control over content.
An educational workshop at the 2017 Issues & Answers conference highlighted heart valve disease and the important role of primary care in its effective management. Across the UK approximately 1.5 million people >65 years are currently affected by the disease numbers predicted to more than double to 3.3 million by 2056.
ESC/EACTS guidelines for Valvular Heart Disease (VHD) management were updated in 2017 and has since impacted individual patient suitability for Aortic Stenosis treatment. A visual summary of the latest VHD management guidelines is now available.
Download yours now!